Elizabeth D. Lightbody
- Cell Biology top 10%
- Hippo pathway signaling and YAP/TAZ 3
-
- Cancer Genomics and Diagnostics 4
-
- Multiple Myeloma Research and Treatments 8
-
- Single-cell and spatial transcriptomics 3
- Protein Degradation and Inhibitors 3
- Glycosylation and Glycoproteins Research 2
- Molecular Biology Techniques and Applications 2
-
- Myeloproliferative Neoplasms: Diagnosis and Treatment 2
- Co-authors
- Christopher J.B. NicolXiaolong YangTaha AzadAbdi GhaffariSandip SenguptaRomanos Sklavenitis‐PistofidisIrene M. GhobrialJean-Baptiste Alberge
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Elizabeth D. Lightbody
19 papers receiving 403 citations
Peers
Comparison fields: 5 of 59
- Cell Biology 142
- Cancer Research 84
- Hematology 49
- Molecular Biology 262
- Oncology 80
Countries citing papers authored by Elizabeth D. Lightbody
This map shows the geographic impact of Elizabeth D. Lightbody's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth D. Lightbody with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth D. Lightbody more than expected).
Fields of papers citing papers by Elizabeth D. Lightbody
This network shows the impact of papers produced by Elizabeth D. Lightbody. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth D. Lightbody. The network helps show where Elizabeth D. Lightbody may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elizabeth D. Lightbody, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 12 | |
| 7 | 2022 | 72 | |
| 8 | 2022 | 1 | |
| 9 | 2022 | 1 | |
| 10 | 2022 | 1 | |
| 11 | 2021 | 1 | |
| 12 | 2021 | 1 | |
| 13 | 2020 | 7 | |
| 14 | 2020 | 20 | |
| 15 | 2019 | 3 | |
| 16 | 2019 | 34 | |
| 17 | 2018 | 56 | |
| 18 | 2018 | 127 | |
| 19 | 2018 | 62 | |
| 20 | 2009 | 2 |
About Elizabeth D. Lightbody
Elizabeth D. Lightbody is a scholar working on Hematology, Cancer Research and Immunology, having authored 21 papers that have together received 406 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (8 papers), Cancer Genomics and Diagnostics (4 papers), Single-cell and spatial transcriptomics (3 papers), Protein Degradation and Inhibitors (3 papers), Hippo pathway signaling and YAP/TAZ (3 papers), Glycosylation and Glycoproteins Research (2 papers), Molecular Biology Techniques and Applications (2 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). The work is most often cited by research in Cell Biology (142 citations), Cancer Research (84 citations) and Hematology (49 citations). Elizabeth D. Lightbody has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Christopher J.B. Nicol, Xiaolong Yang, Taha Azad, Abdi Ghaffari, Sandip Sengupta, Romanos Sklavenitis‐Pistofidis, Irene M. Ghobrial, Jean-Baptiste Alberge, Ankit K. Dutta and Gad Getz. Their work appears in journals such as Nature Communications, Blood and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.